Hep C treatment: the new era begins

The first of March 2016 may go down in history as the day that changed the lives of many of Australia’s estimated 230,000 citizens living with hepatitis C.

The PBS listing of three new medicines which have cure rates of up to 99% brings the new, highly efficacious treatments into the reach of ordinary Australians.

Gilead’s ledipasvir/sofosbuvir combination is “the first one-pill-once&ndash